Clinical Trial Update: A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluated adjuvant chemotherapy with doxorubicin, ifosfamide, and mesna in high-grade adult extremity soft tissue sarcoma. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• IFOSFAMIDE (IFOSFAMIDE)
• MESNA (MESNA)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Sarcoma | Phase 3 | Status: COMPLETED